MINOCYCLINE HYDROCHLORIDE

MINOCYCLINE HYDROCHLORIDE was reported 5930 times

MINOCYCLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 31 0.2081
1 RETINITIS 302 0.1747
2 INTESTINAL SEPSIS 42 0.1603
3 SCLERAL PIGMENTATION 14 0.1474
4 LUPUS VULGARIS 185 0.1468
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 86 0.1287
6 CONJUNCTIVAL PIGMENTATION 5 0.1250
7 HYPOCHOLESTEROLAEMIA 40 0.1133
8 FACET JOINT SYNDROME 341 0.1046
9 RHEUMATIC FEVER 459 0.1029
10 OCHRONOSIS 7 0.0986
11 BAROTRAUMA 9 0.0978
12 ONYCHOMADESIS 395 0.0940
13 OVERLAP SYNDROME 64 0.0914
14 BONE HYPERPIGMENTATION 7 0.0864
15 PERIPHERAL VENOUS DISEASE 315 0.0771
16 BONE EROSION 267 0.0754
17 ONYCHOMYCOSIS 330 0.0751
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 537 0.0749
19 C-REACTIVE PROTEIN ABNORMAL 467 0.0727
20 DEEP VEIN THROMBOSIS POSTOPERATIVE 129 0.0644
21 C-REACTIVE PROTEIN 59 0.0636
22 DUODENAL ULCER PERFORATION 448 0.0602
23 POLYARTERITIS NODOSA 35 0.0599
24 FINGER DEFORMITY 265 0.0547
25 DISLOCATION OF VERTEBRA 119 0.0521
26 PEMPHIGUS 650 0.0519
27 RHEUMATOID FACTOR POSITIVE 299 0.0517
28 X-RAY ABNORMAL 92 0.0514
29 SERONEGATIVE ARTHRITIS 58 0.0506
30 BREAST CANCER STAGE III 309 0.0477
31 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 5 0.0476
32 SWOLLEN JOINT COUNT INCREASED 144 0.0451
33 BLEPHAROSPASM 283 0.0449
34 FOLLICULITIS 459 0.0437
35 GRIP STRENGTH 10 0.0437
36 HELICOBACTER INFECTION 431 0.0419
37 HYPERCHOLESTEROLAEMIA 400 0.0414
38 PRODUCT LABEL CONFUSION 238 0.0408
39 SWOLLEN JOINT COUNT 10 0.0400
40 PERICARDITIS 670 0.0398
41 HAND DEFORMITY 511 0.0389
42 MUSCLE INJURY 319 0.0385
43 RED BLOOD CELL SEDIMENTATION RATE INCREASED 403 0.0364
44 SYNOVITIS 649 0.0360
45 GRIP STRENGTH DECREASED 309 0.0351
46 LIP DRY 307 0.0338
47 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 70 0.0338
48 EXOSTOSIS 308 0.0337
49 NAIL DISORDER 285 0.0325
50 LIVE BIRTH 270 0.0322
51 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 18 0.0321
52 BURSITIS 376 0.0310
53 BACK INJURY 314 0.0288
54 LUPUS-LIKE SYNDROME 258 0.0284
55 WOUND INFECTION 293 0.0267
56 GLOSSODYNIA 574 0.0256
57 JOINT DISLOCATION 265 0.0250
58 WOUND 688 0.0246
59 COELIAC DISEASE 241 0.0245
60 FOOT DEFORMITY 272 0.0245
61 APPARENT DEATH 87 0.0241
62 CONGENITAL ANOMALY 184 0.0237
63 JOINT RANGE OF MOTION DECREASED 318 0.0237
64 CONTRAINDICATED PRODUCT ADMINISTERED 689 0.0227
65 JOINT ARTHROPLASTY 40 0.0223
66 NAIL OPERATION 9 0.0217
67 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 49 0.0212
68 POLYSEROSITIS 9 0.0211
69 GLIOSIS 9 0.0210
70 PORPHYRIA ACUTE 30 0.0209
71 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 135 0.0208
72 BENIGN INTRACRANIAL HYPERTENSION 26 0.0207
73 SYSTEMIC LUPUS ERYTHEMATOSUS 698 0.0196
74 C-REACTIVE PROTEIN INCREASED 699 0.0192
75 FIBROMYALGIA 458 0.0188
76 GINGIVAL DISCOLOURATION 10 0.0186
77 ADVERSE REACTION 242 0.0182
78 MONONEUROPATHY MULTIPLEX 8 0.0173
79 ENTEROCOCCAL SEPSIS 14 0.0173
80 TYPE 2 DIABETES MELLITUS 582 0.0173
81 IRRITABLE BOWEL SYNDROME 369 0.0172
82 OVARIAN FAILURE 9 0.0168
83 VASCULITIS NECROTISING 12 0.0168
84 INFECTIVE SPONDYLITIS 4 0.0166
85 OBESITY 259 0.0162
86 LIVER INJURY 395 0.0161
87 DEATH NEONATAL 22 0.0158
88 SPONDYLITIS 56 0.0154
89 EOSINOPHILIC MYOCARDITIS 11 0.0151
90 TASTE DISORDER 305 0.0150
91 SERUM SICKNESS-LIKE REACTION 9 0.0143
92 PSORIATIC ARTHROPATHY 575 0.0142
93 OSTEOARTHRITIS 585 0.0138
94 AUTOIMMUNE DISORDER 133 0.0136
95 HEPATIC CIRRHOSIS 252 0.0134
96 ANTI-THYROID ANTIBODY POSITIVE 6 0.0131
97 LIVER FUNCTION TEST INCREASED 279 0.0130
98 IMMUNOGLOBULIN G4 RELATED DISEASE 4 0.0125
99 THERAPEUTIC PRODUCT EFFECT DECREASED 554 0.0124
100 TERMINAL STATE 82 0.0122
101 NORMAL NEWBORN 65 0.0119
102 DRUG-INDUCED LIVER INJURY 373 0.0119
103 THROMBOPHLEBITIS MIGRANS 4 0.0118
104 POUCHITIS 10 0.0116
105 EOSINOPHILIC PNEUMONIA ACUTE 10 0.0115
106 IMPAIRED HEALING 377 0.0115
107 INFUSION SITE REACTION 34 0.0114
108 GAIT INABILITY 380 0.0114
109 BLOOD CHOLESTEROL INCREASED 528 0.0113
110 HEPATITIS 282 0.0110
111 NIGHT SWEATS 346 0.0107
112 PARONYCHIA 47 0.0107
113 SCLERAL DISCOLOURATION 7 0.0107
114 BASEDOW'S DISEASE 5 0.0106
115 DERMATITIS ACNEIFORM 64 0.0105
116 JOINT STIFFNESS 274 0.0104
117 ILEITIS 4 0.0104
118 DRUG INTOLERANCE 993 0.0103
119 TUBERCULIN TEST POSITIVE 26 0.0103
120 INFUSION RELATED REACTION 675 0.0102
121 LYMPHOCYTE STIMULATION TEST POSITIVE 8 0.0100
122 PROCTITIS ULCERATIVE 6 0.0100
123 SPINAL FUSION SURGERY 40 0.0098
124 PREMATURE MENOPAUSE 9 0.0097
125 SEROUS RETINAL DETACHMENT 8 0.0095
126 ARTHROPATHY 509 0.0091
127 HEPATIC ENZYME INCREASED 619 0.0091
128 DRUG TOLERANCE DECREASED 25 0.0089
129 STOMATITIS 533 0.0088
130 EPILEPSY 264 0.0086
131 SCIATICA 137 0.0086
132 EAR INFECTION 228 0.0086
133 BORDERLINE PERSONALITY DISORDER 6 0.0085
134 RHEUMATOID ARTHRITIS 949 0.0083
135 WALKING AID USER 55 0.0083
136 SOMATIC SYMPTOM DISORDER 9 0.0083
137 BREAST CANCER STAGE II 68 0.0082
138 PULMONARY THROMBOSIS 88 0.0081
139 MOBILITY DECREASED 562 0.0078
140 OSTEOPOROSIS 320 0.0078
141 PHOTOSENSITIVITY REACTION 126 0.0076
142 BLISTER 427 0.0076
143 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 6 0.0075
144 TREATMENT FAILURE 620 0.0075
145 SLEEP DISORDER 522 0.0074
146 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 24 0.0074
147 INFLAMMATION 379 0.0073
148 XEROSIS 9 0.0073
149 PRESCRIBED UNDERDOSE 143 0.0072
150 LOWER RESPIRATORY TRACT INFECTION 318 0.0070
151 CORNEAL EPITHELIUM DEFECT 4 0.0069
152 ANTIPHOSPHOLIPID SYNDROME 11 0.0068
153 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 5 0.0068
154 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 476 0.0067
155 INTENTIONAL PRODUCT USE ISSUE 585 0.0067
156 MATERNAL EXPOSURE DURING PREGNANCY 591 0.0066
157 PULMONARY FIBROSIS 127 0.0066
158 LUNG DISORDER 319 0.0065
159 EXPOSURE DURING PREGNANCY 404 0.0065
160 PIGMENTATION DISORDER 40 0.0065
161 HIP ARTHROPLASTY 99 0.0065
162 MONOCYTOSIS 4 0.0064
163 BREAST FEEDING 5 0.0064
164 MATERNAL EXPOSURE TIMING UNSPECIFIED 24 0.0064
165 JOINT SWELLING 768 0.0064
166 LOWER LIMB FRACTURE 121 0.0063
167 ILL-DEFINED DISORDER 382 0.0063
168 EYE INJURY 19 0.0062
169 INJURY 439 0.0062
170 HYPERVIGILANCE 6 0.0062
171 GENERAL PHYSICAL HEALTH DETERIORATION 709 0.0061
172 ULCER HAEMORRHAGE 41 0.0061
173 WHEEZING 357 0.0060
174 SWELLING 556 0.0059
175 KNEE ARTHROPLASTY 124 0.0059
176 PRESCRIBED OVERDOSE 113 0.0058
177 GINGIVAL ERYTHEMA 5 0.0058
178 NECK PAIN 319 0.0057
179 INFLAMMATORY BOWEL DISEASE 55 0.0056
180 MUSCULOSKELETAL STIFFNESS 484 0.0055
181 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 6 0.0053
182 VENOUS THROMBOSIS LIMB 11 0.0053
183 GINGIVAL ULCERATION 4 0.0053
184 JOINT DESTRUCTION 8 0.0051
185 DISCOMFORT 311 0.0051
186 RETINAL PIGMENTATION 4 0.0051
187 AUTOIMMUNE HEPATITIS 35 0.0050
188 PERFORATION 4 0.0050
189 DRY MOUTH 401 0.0049
190 ANTINUCLEAR ANTIBODY POSITIVE 16 0.0049
191 SKIN HYPERPIGMENTATION 42 0.0049
192 MUSCLE SPASTICITY 60 0.0049
193 MUSCULOSKELETAL PAIN 254 0.0048
194 GENERALISED ANXIETY DISORDER 7 0.0048
195 DYSPEPSIA 462 0.0047
196 PAPILLARY THYROID CANCER 8 0.0046
197 GASTROINTESTINAL FISTULA 4 0.0046
198 GASTROOESOPHAGEAL REFLUX DISEASE 362 0.0045
199 PERIPHERAL SENSORY NEUROPATHY 26 0.0044
200 INJECTION SITE REACTION 297 0.0043
201 PEMPHIGOID 32 0.0042
202 EOSINOPHILIC PNEUMONIA 13 0.0041
203 STENT PLACEMENT 33 0.0041
204 WOUND SECRETION 16 0.0041
205 PUSTULAR PSORIASIS 14 0.0041
206 HIDRADENITIS 37 0.0041
207 RECTAL POLYP 4 0.0041
208 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 69 0.0040
209 ABDOMINAL DISCOMFORT 674 0.0040
210 VARICELLA ZOSTER VIRUS INFECTION 8 0.0039
211 GASTROINTESTINAL DISORDER 345 0.0038
212 MIGRAINE 364 0.0038
213 ABDOMINAL DISTENSION 393 0.0038
214 ARTHRITIS 296 0.0038
215 TOOTH DISCOLOURATION 11 0.0037
216 INTERSTITIAL LUNG DISEASE 176 0.0036
217 HYPOAESTHESIA 539 0.0036
218 DIVERTICULITIS 99 0.0036
219 SKIN ODOUR ABNORMAL 14 0.0036
220 EAR PAIN 69 0.0035
221 NONINFECTIVE GINGIVITIS 5 0.0035
222 SENSE OF OPPRESSION 4 0.0034
223 GINGIVAL SWELLING 15 0.0034
224 ADVERSE DRUG REACTION 302 0.0034
225 EXPOSURE DURING BREAST FEEDING 11 0.0033
226 FUNGAEMIA 5 0.0032
227 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 152 0.0032
228 HYPOPROTEINAEMIA 6 0.0032
229 IDIOPATHIC INTRACRANIAL HYPERTENSION 7 0.0031
230 AORTIC VALVE DISEASE 5 0.0031
231 OBLITERATIVE BRONCHIOLITIS 4 0.0030
232 RESPIRATORY DISORDER 91 0.0030
233 URTICARIA 507 0.0030
234 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 7 0.0030
235 HYPOALBUMINAEMIA 23 0.0030
236 INCORRECT PRODUCT ADMINISTRATION DURATION 64 0.0030
237 STENOTROPHOMONAS INFECTION 4 0.0029
238 ALOPECIA 577 0.0029
239 LIVER DISORDER 130 0.0029
240 HYPERSENSITIVITY 544 0.0029
241 ULCERATIVE KERATITIS 8 0.0029
242 HEPATIC NECROSIS 11 0.0029
243 DISSEMINATED INTRAVASCULAR COAGULATION 41 0.0029
244 CONFUSIONAL STATE 469 0.0029
245 SENSITIVITY OF TEETH 5 0.0029
246 APPLICATION SITE INFLAMMATION 4 0.0029
247 SUSPECTED OFF LABEL USE 13 0.0029
248 MUSCULAR WEAKNESS 326 0.0029
249 PRODUCT USE ISSUE 539 0.0029
250 PERIODONTAL DISEASE 4 0.0029
251 JAUNDICE CHOLESTATIC 10 0.0028
252 NAIL DISCOLOURATION 11 0.0028
253 ROAD TRAFFIC ACCIDENT 116 0.0028
254 CROHN'S DISEASE 19 0.0028
255 DELIRIUM 96 0.0028
256 RASH VESICULAR 13 0.0027
257 ADVERSE EVENT 244 0.0026
258 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
259 GASTROINTESTINAL INJURY 7 0.0026
260 GINGIVAL RECESSION 5 0.0026
261 UPPER RESPIRATORY TRACT INFECTION 120 0.0026
262 CONVERSION DISORDER 5 0.0026
263 PURULENCE 5 0.0026
264 PRODUCT USE IN UNAPPROVED INDICATION 636 0.0026
265 ERYTHEMA NODOSUM 9 0.0026
266 MYOSITIS 23 0.0026
267 TONGUE DISCOLOURATION 11 0.0025
268 OEDEMA 136 0.0025
269 GASTRIC DISORDER 86 0.0025
270 PANNICULITIS 6 0.0025
271 LYMPHADENITIS 6 0.0025
272 SEBORRHOEIC DERMATITIS 4 0.0024
273 UNDERDOSE 176 0.0024
274 PERIPHERAL SWELLING 371 0.0024
275 HYPERTENSION 509 0.0024
276 VISUAL IMPAIRMENT 297 0.0024
277 GINGIVAL PAIN 19 0.0024
278 AUTOIMMUNE THYROIDITIS 9 0.0024
279 DISABILITY 47 0.0024
280 CONDITION AGGRAVATED 721 0.0024
281 PRODUCT QUALITY ISSUE 318 0.0023
282 FREQUENT BOWEL MOVEMENTS 63 0.0023
283 OEDEMA PERIPHERAL 284 0.0023
284 CARDIAC TAMPONADE 11 0.0023
285 THERAPY NON-RESPONDER 104 0.0023
286 PERIODONTITIS 5 0.0023
287 EXPOSED BONE IN JAW 5 0.0023
288 MEMORY IMPAIRMENT 317 0.0023
289 FEAR OF DISEASE 4 0.0022
290 PSEUDOMEMBRANOUS COLITIS 5 0.0022
291 STAPHYLOCOCCAL SEPSIS 11 0.0022
292 HERPES ZOSTER 128 0.0022
293 DECREASED APPETITE 513 0.0022
294 PARAESTHESIA 347 0.0022
295 INFECTION 316 0.0022
296 PNEUMONIA 706 0.0022
297 PROCTITIS 6 0.0021
298 HYPERCOAGULATION 4 0.0021
299 HYPOMAGNESAEMIA 29 0.0021
300 CLOSTRIDIAL INFECTION 7 0.0021
301 NASOPHARYNGITIS 377 0.0020
302 HEPATIC FUNCTION ABNORMAL 76 0.0020
303 MULTI-ORGAN DISORDER 4 0.0020
304 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 5 0.0020
305 ARTHRALGIA 833 0.0020
306 THYROIDITIS 6 0.0020
307 ABDOMINAL PAIN UPPER 409 0.0020
308 WEIGHT INCREASED 443 0.0020
309 VASCULITIS 23 0.0020
310 RASH 849 0.0019
311 PYODERMA GANGRENOSUM 7 0.0019
312 PHYSICAL DECONDITIONING 5 0.0019
313 CONTUSION 184 0.0019
314 DEPRESSION 429 0.0019
315 DEEP VEIN THROMBOSIS 121 0.0019
316 CHEILITIS 10 0.0018
317 DUODENAL ULCER 13 0.0018
318 MELANOCYTIC NAEVUS 8 0.0018
319 GINGIVAL DISORDER 7 0.0018
320 FOETAL EXPOSURE DURING PREGNANCY 148 0.0018
321 MUSCLE SPASMS 334 0.0018
322 BRONCHITIS 134 0.0018
323 INTRACRANIAL PRESSURE INCREASED 10 0.0018
324 SERUM SICKNESS 5 0.0018
325 SINUSITIS 183 0.0018
326 PAIN IN EXTREMITY 526 0.0018
327 DUODENAL ULCER HAEMORRHAGE 5 0.0017
328 ORAL PRURITUS 4 0.0017
329 COLITIS ULCERATIVE 77 0.0017
330 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 44 0.0017
331 TACHYCARDIA 151 0.0017
332 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
333 INSOMNIA 446 0.0017
334 SELF ESTEEM DECREASED 4 0.0017
335 NEURODERMATITIS 6 0.0016
336 PAIN 990 0.0016
337 PREGNANCY 32 0.0016
338 HEPATITIS B REACTIVATION 5 0.0016
339 TRANSAMINASES INCREASED 35 0.0016
340 CANCER PAIN 4 0.0016
341 MENINGITIS ASEPTIC 7 0.0016
342 LYMPHOCYTE COUNT INCREASED 5 0.0015
343 BLOOD ALBUMIN DECREASED 12 0.0015
344 MALAISE 660 0.0015
345 ROSACEA 7 0.0015
346 ANAL FISTULA 8 0.0015
347 SKIN PAPILLOMA 6 0.0015
348 TYPE 1 DIABETES MELLITUS 9 0.0015
349 APPLICATION SITE HAEMORRHAGE 4 0.0015
350 CHOLANGITIS 9 0.0015
351 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
352 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0014
353 GASTRIC ULCER HAEMORRHAGE 8 0.0014
354 WEIGHT FLUCTUATION 15 0.0014
355 EOSINOPHILIA 25 0.0014
356 ASTHMA 160 0.0014
357 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
358 IRON DEFICIENCY ANAEMIA 13 0.0014
359 OFF LABEL USE 1231 0.0014
360 APPLICATION SITE SWELLING 7 0.0014
361 HAEMORRHAGIC DIATHESIS 5 0.0014
362 ADRENAL INSUFFICIENCY 17 0.0014
363 PULMONARY EMBOLISM 133 0.0014
364 DERMATITIS EXFOLIATIVE 7 0.0014
365 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
366 DRUG TOLERANCE 7 0.0014
367 CHAPPED LIPS 6 0.0014
368 SCLERODERMA 5 0.0014
369 PSYCHIATRIC SYMPTOM 10 0.0014
370 AMYLASE INCREASED 5 0.0014
371 THROMBOSIS 109 0.0014
372 POLYARTHRITIS 7 0.0013
373 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
374 SKIN DISORDER 44 0.0013
375 HAEMOGLOBIN DECREASED 135 0.0013
376 DIZZINESS 654 0.0013
377 RECTAL CANCER 4 0.0013
378 ACUTE RESPIRATORY DISTRESS SYNDROME 23 0.0013
379 DRUG ERUPTION 23 0.0013
380 BRONCHOPULMONARY ASPERGILLOSIS 10 0.0013
381 PRE-EXISTING CONDITION IMPROVED 8 0.0013
382 ORAL INFECTION 5 0.0013
383 PULMONARY MASS 19 0.0013
384 HYPERBILIRUBINAEMIA 13 0.0013
385 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
386 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
387 TENDERNESS 13 0.0012
388 POST PROCEDURAL INFECTION 10 0.0012
389 ORAL DISORDER 9 0.0012
390 NODULE 16 0.0012
391 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
392 MEDICATION ERROR 68 0.0012
393 GOITRE 5 0.0012
394 GAMMA-GLUTAMYLTRANSFERASE INCREASED 27 0.0012
395 LYMPHADENOPATHY 43 0.0012
396 AMNESIA 79 0.0012
397 ORGANISING PNEUMONIA 6 0.0012
398 SEPSIS 135 0.0012
399 PYREXIA 416 0.0012
400 HYPERTRIGLYCERIDAEMIA 7 0.0012
401 ERYTHEMA MULTIFORME 11 0.0012
402 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
403 THERAPEUTIC RESPONSE DECREASED 71 0.0012
404 PURULENT DISCHARGE 5 0.0012
405 HEADACHE 730 0.0012
406 MYOPATHY 10 0.0012
407 PAPULE 8 0.0011
408 VOMITING 532 0.0011
409 SKIN LESION 31 0.0011
410 ANAL FISSURE 6 0.0011
411 GINGIVITIS 6 0.0011
412 SCAR 19 0.0011
413 PAPILLOEDEMA 5 0.0011
414 NEUTROPHIL COUNT DECREASED 45 0.0011
415 RASH PUSTULAR 8 0.0011
416 FEELING HOT 67 0.0011
417 NAUSEA 863 0.0011
418 PNEUMONIA BACTERIAL 10 0.0011
419 SPINAL COMPRESSION FRACTURE 9 0.0011
420 NEPHROGENIC ANAEMIA 5 0.0011
421 SKIN INFECTION 12 0.0011
422 GENERAL SYMPTOM 8 0.0011
423 HYPOKALAEMIA 49 0.0011
424 PARANASAL SINUS DISCOMFORT 4 0.0011
425 ASPARTATE AMINOTRANSFERASE INCREASED 56 0.0011
426 MENINGITIS 7 0.0010
427 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
428 BLOOD MAGNESIUM DECREASED 9 0.0010
429 OESOPHAGEAL ULCER 4 0.0010
430 ASTHENIA 391 0.0010
431 MOUTH SWELLING 6 0.0010
432 ENTEROCOLITIS 6 0.0010
433 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
434 DRUG INEFFECTIVE 1338 0.0010
435 PROTHROMBIN TIME PROLONGED 6 0.0010
436 FATIGUE 778 0.0010
437 CANDIDIASIS 4 0.0010
438 SKIN REACTION 14 0.0010
439 CYSTITIS HAEMORRHAGIC 4 0.0010
440 SEPTIC SHOCK 43 0.0010
441 LABORATORY TEST ABNORMAL 29 0.0010
442 RENAL FAILURE 130 0.0010
443 CACHEXIA 5 0.0010
444 GENERALISED OEDEMA 12 0.0010
445 TONGUE DISORDER 7 0.0010
446 FALL 321 0.0010
447 GASTROINTESTINAL PERFORATION 4 0.0010
448 BLOOD UREA INCREASED 16 0.0010
449 RECTAL HAEMORRHAGE 41 0.0010
450 HYPOCALCAEMIA 18 0.0010
451 SENSITIVITY TO WEATHER CHANGE 5 0.0009
452 INTESTINAL STENOSIS 4 0.0009
453 ALANINE AMINOTRANSFERASE INCREASED 58 0.0009
454 AORTIC VALVE INCOMPETENCE 4 0.0009
455 COMPRESSION FRACTURE 5 0.0009
456 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
457 DIARRHOEA 599 0.0009
458 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
459 PERITONITIS 19 0.0009
460 ASPERGILLUS INFECTION 6 0.0009
461 THYROID DISORDER 14 0.0009
462 CARDIAC FAILURE ACUTE 6 0.0009
463 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
464 STREPTOCOCCAL INFECTION 5 0.0009
465 PSORIASIS 117 0.0009
466 HEPATIC FAILURE 27 0.0009
467 LIVER FUNCTION TEST ABNORMAL 26 0.0009
468 TOXIC SKIN ERUPTION 9 0.0009
469 ILEUS 11 0.0009
470 GINGIVAL BLEEDING 12 0.0009
471 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
472 ONYCHOCLASIS 6 0.0009
473 VISUAL DISTURBANCE 5 0.0009
474 PANCREATITIS 46 0.0009
475 NEOPLASM MALIGNANT 58 0.0009
476 MULTI-ORGAN FAILURE 15 0.0009
477 ORAL DISCOMFORT 12 0.0009
478 DYSPNOEA 488 0.0009
479 DECUBITUS ULCER 7 0.0009
480 GASTRITIS EROSIVE 4 0.0009
481 SPLENOMEGALY 10 0.0009
482 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
483 PULMONARY TOXICITY 6 0.0008
484 CHEST PAIN 157 0.0008
485 PNEUMONIA ASPIRATION 21 0.0008
486 EOSINOPHIL COUNT INCREASED 7 0.0008
487 HYPERLIPIDAEMIA 10 0.0008
488 DERMATITIS BULLOUS 6 0.0008
489 TOOTHACHE 15 0.0008
490 ASCITES 24 0.0008
491 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
492 DIABETIC NEUROPATHY 4 0.0008
493 PYELONEPHRITIS 7 0.0008
494 SUNBURN 6 0.0008
495 MALNUTRITION 9 0.0008
496 PROTEIN URINE PRESENT 4 0.0008
497 OSTEOPENIA 12 0.0008
498 DERMATITIS CONTACT 9 0.0008
499 OVERDOSE 170 0.0008
500 HEPATIC CYTOLYSIS 10 0.0008
501 BODY TEMPERATURE INCREASED 16 0.0008
502 FUNGAL INFECTION 26 0.0008
503 ENDOCARDITIS 4 0.0008
504 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
505 SKIN NECROSIS 4 0.0008
506 FACE OEDEMA 13 0.0008
507 HEPATITIS ACUTE 5 0.0008
508 TONSILLITIS 4 0.0008
509 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
510 RETINAL DETACHMENT 7 0.0008
511 UROSEPSIS 7 0.0008
512 SCRATCH 8 0.0008
513 SERUM FERRITIN INCREASED 4 0.0008
514 HAEMATOCRIT DECREASED 15 0.0008
515 PANCREATITIS ACUTE 17 0.0008
516 SKIN MASS 5 0.0007
517 POST-TRAUMATIC STRESS DISORDER 5 0.0007
518 JAUNDICE 20 0.0007
519 PLEURAL EFFUSION 45 0.0007
520 BACK DISORDER 12 0.0007
521 SKIN ULCER 19 0.0007
522 OESOPHAGITIS 8 0.0007
523 CYSTIC FIBROSIS 4 0.0007
524 LARGE INTESTINE POLYP 5 0.0007
525 STEVENS-JOHNSON SYNDROME 16 0.0007
526 NECROSIS 4 0.0007
527 DERMATITIS 15 0.0007
528 ANGIOPATHY 4 0.0007
529 MACULAR OEDEMA 4 0.0007
530 RENAL TUBULAR NECROSIS 7 0.0007
531 RIGHT VENTRICULAR FAILURE 5 0.0007
532 ABDOMINAL PAIN 165 0.0007
533 SKIN TOXICITY 4 0.0007
534 CHOLECYSTITIS ACUTE 4 0.0007
535 PLATELET COUNT DECREASED 75 0.0007
536 DIVERTICULUM 5 0.0007
537 NEUTROPHILIA 4 0.0007
538 ROTATOR CUFF SYNDROME 9 0.0007
539 AGRANULOCYTOSIS 13 0.0007
540 ANOREXIA 9 0.0007
541 STAPHYLOCOCCAL INFECTION 23 0.0007
542 SKIN DISCOLOURATION 32 0.0007
543 BLOOD URIC ACID INCREASED 4 0.0007
544 PHOTOPHOBIA 13 0.0007
545 PLATELET COUNT INCREASED 9 0.0007
546 HYPERVENTILATION 4 0.0007
547 RALES 4 0.0007
548 TOOTH ABSCESS 7 0.0007
549 SPINAL OSTEOARTHRITIS 6 0.0007
550 RASH MACULO-PAPULAR 15 0.0007
551 CHOLECYSTITIS 8 0.0007
552 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
553 HOSPITALISATION 103 0.0007
554 ORAL HERPES 13 0.0007
555 FEBRILE NEUTROPENIA 44 0.0007
556 ACNE 50 0.0007
557 PRURITUS 252 0.0007
558 FEELING ABNORMAL 157 0.0007
559 DEVICE RELATED INFECTION 10 0.0006
560 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
561 CONJUNCTIVITIS 12 0.0006
562 CYST 8 0.0006
563 ANXIETY 183 0.0006
564 FLANK PAIN 6 0.0006
565 BONE MARROW FAILURE 13 0.0006
566 ASPIRATION 7 0.0006
567 SWELLING OF EYELID 4 0.0006
568 SPINAL DISORDER 6 0.0006
569 COLITIS 24 0.0006
570 DENTAL CARIES 7 0.0006
571 FURUNCLE 5 0.0006
572 EYE INFLAMMATION 6 0.0006
573 ABSCESS 10 0.0006
574 HYPOTHYROIDISM 20 0.0006
575 INFUSION SITE PAIN 8 0.0006
576 THROMBOCYTOPENIA 69 0.0006
577 GASTROENTERITIS 9 0.0006
578 HAEMORRHOIDS 12 0.0006
579 DRY SKIN 82 0.0006
580 PANCYTOPENIA 34 0.0006
581 ESCHERICHIA INFECTION 5 0.0006
582 OSTEOMYELITIS 11 0.0006
583 TOOTH INFECTION 8 0.0006
584 IMMUNODEFICIENCY 9 0.0006
585 RESPIRATORY FAILURE 44 0.0006
586 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
587 WHITE BLOOD CELL COUNT DECREASED 65 0.0006
588 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
589 WEIGHT DECREASED 166 0.0006
590 COLITIS ISCHAEMIC 4 0.0006
591 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
592 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
593 MYOCARDIAL INFARCTION 102 0.0006
594 PSEUDOMONAS INFECTION 5 0.0006
595 ORAL PAIN 13 0.0006
596 GASTRIC ULCER 11 0.0006
597 LYMPHOEDEMA 4 0.0006
598 EYE DISCHARGE 6 0.0006
599 HYPERTRANSAMINASAEMIA 4 0.0006
600 GAIT DISTURBANCE 109 0.0006
601 SMALL INTESTINAL OBSTRUCTION 7 0.0006
602 TUMOUR LYSIS SYNDROME 5 0.0006
603 PNEUMOTHORAX 9 0.0006
604 IMMUNOSUPPRESSION 5 0.0006
605 LYMPHOCYTE COUNT DECREASED 10 0.0006
606 ULCER 9 0.0006
607 SKIN FISSURES 11 0.0006
608 FACIAL PAIN 5 0.0006
609 RENAL IMPAIRMENT 47 0.0006
610 HAEMOLYTIC ANAEMIA 5 0.0006
611 BLOOD BILIRUBIN INCREASED 15 0.0006
612 BONE DISORDER 10 0.0005
613 APPLICATION SITE PAIN 12 0.0005
614 RESPIRATORY DISTRESS 15 0.0005
615 SENSITIVE SKIN 4 0.0005
616 CEREBRAL DISORDER 4 0.0005
617 HIATUS HERNIA 7 0.0005
618 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
619 VENTRICULAR FIBRILLATION 6 0.0005
620 APPENDICITIS 5 0.0005
621 RASH PRURITIC 29 0.0005
622 HYDRONEPHROSIS 4 0.0005
623 CHROMATURIA 12 0.0005
624 ARTERIOSCLEROSIS 5 0.0005
625 REBOUND EFFECT 6 0.0005
626 SCAB 6 0.0005
627 MOUTH ULCERATION 11 0.0005
628 AGEUSIA 13 0.0005
629 ATELECTASIS 5 0.0005
630 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
631 PNEUMONITIS 14 0.0005
632 THROMBOTIC MICROANGIOPATHY 5 0.0005
633 BASAL CELL CARCINOMA 8 0.0005
634 VITAMIN D DEFICIENCY 5 0.0005
635 ACUTE HEPATIC FAILURE 7 0.0005
636 PULMONARY HAEMORRHAGE 4 0.0005
637 AFFECTIVE DISORDER 4 0.0005
638 CYANOSIS 8 0.0005
639 ANAEMIA 97 0.0005
640 BACTERAEMIA 6 0.0005
641 RENAL CYST 4 0.0005
642 RESPIRATORY TRACT CONGESTION 8 0.0005
643 RASH GENERALISED 13 0.0005
644 ABORTION SPONTANEOUS 20 0.0005
645 LEUKOCYTOSIS 9 0.0005
646 RENAL DISORDER 23 0.0005
647 CEREBRAL INFARCTION 12 0.0005
648 HYPERKALAEMIA 17 0.0005
649 HYPERTHYROIDISM 7 0.0005
650 BACTERIAL INFECTION 9 0.0005
651 HAIR COLOUR CHANGES 6 0.0005
652 EMBOLISM 4 0.0005
653 SHOCK 11 0.0005
654 DERMATITIS ALLERGIC 6 0.0005
655 SWELLING FACE 31 0.0005
656 TREATMENT NONCOMPLIANCE 26 0.0005
657 BRAIN OEDEMA 6 0.0005
658 FLUID RETENTION 24 0.0005
659 DYSGEUSIA 35 0.0005
660 ERYTHEMA 96 0.0005
661 ANURIA 4 0.0005
662 CARDIAC FAILURE 37 0.0005
663 RESPIRATORY TRACT INFECTION 12 0.0005
664 SKIN LACERATION 5 0.0005
665 VERTIGO 28 0.0005
666 PAIN IN JAW 13 0.0005
667 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
668 BLOOD CALCIUM INCREASED 4 0.0005
669 ORAL CANDIDIASIS 6 0.0005
670 HYPOXIA 16 0.0005
671 SARS-COV-2 TEST POSITIVE 6 0.0005
672 LUNG INFILTRATION 4 0.0005
673 PURPURA 4 0.0005
674 NERVE INJURY 5 0.0004
675 HAIR TEXTURE ABNORMAL 6 0.0004
676 RASH PAPULAR 10 0.0004
677 OSTEONECROSIS OF JAW 11 0.0004
678 UVEITIS 6 0.0004
679 MITRAL VALVE INCOMPETENCE 5 0.0004
680 MYOCARDITIS 5 0.0004
681 PERICARDIAL EFFUSION 10 0.0004
682 EYELID OEDEMA 5 0.0004
683 MASS 6 0.0004
684 DRUG RESISTANCE 11 0.0004
685 DEFORMITY 4 0.0004
686 ABORTION INDUCED 4 0.0004
687 INTESTINAL OBSTRUCTION 16 0.0004
688 DIPLOPIA 11 0.0004
689 SPUTUM DISCOLOURED 4 0.0004
690 BLOOD URINE PRESENT 8 0.0004
691 COAGULOPATHY 7 0.0004
692 LEUKOPENIA 21 0.0004
693 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
694 WRIST FRACTURE 5 0.0004
695 POST PROCEDURAL COMPLICATION 8 0.0004
696 ACUTE RESPIRATORY FAILURE 8 0.0004
697 INFLUENZA LIKE ILLNESS 34 0.0004
698 HEPATOMEGALY 4 0.0004
699 CARDIOMEGALY 5 0.0004
700 BLOOD PRESSURE DECREASED 27 0.0004
701 TENDON RUPTURE 5 0.0004
702 LIGAMENT SPRAIN 4 0.0004
703 APPLICATION SITE IRRITATION 5 0.0004
704 SALIVARY HYPERSECRETION 4 0.0004
705 RASH ERYTHEMATOUS 19 0.0004
706 EMPHYSEMA 4 0.0004
707 NEUTROPHIL COUNT INCREASED 4 0.0004
708 EUPHORIC MOOD 4 0.0004
709 LYMPHOMA 6 0.0004
710 ANAPHYLACTIC SHOCK 10 0.0004
711 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
712 ACUTE MYELOID LEUKAEMIA 6 0.0004
713 RESTLESS LEGS SYNDROME 7 0.0004
714 HAEMATURIA 13 0.0004
715 NEUROPATHY PERIPHERAL 36 0.0004
716 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
717 DYSMENORRHOEA 5 0.0004
718 CELLULITIS 19 0.0004
719 DYSPNOEA EXERTIONAL 14 0.0004
720 SUICIDAL IDEATION 34 0.0004
721 PAIN OF SKIN 10 0.0004
722 PROTEINURIA 7 0.0004
723 BLOOD CREATININE INCREASED 24 0.0004
724 OROPHARYNGEAL PAIN 34 0.0004
725 SLEEP APNOEA SYNDROME 7 0.0004
726 GASTROINTESTINAL PAIN 4 0.0004
727 ECZEMA 19 0.0004
728 ERUCTATION 7 0.0004
729 CYTOMEGALOVIRUS INFECTION 6 0.0004
730 RHABDOMYOLYSIS 15 0.0004
731 HUNGER 5 0.0004
732 INTESTINAL PERFORATION 4 0.0004
733 OCULAR DISCOMFORT 4 0.0004
734 BLOOD CALCIUM DECREASED 4 0.0004
735 CANDIDA INFECTION 6 0.0004
736 SWOLLEN TONGUE 11 0.0004
737 HYPOPHAGIA 9 0.0004
738 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
739 SUBDURAL HAEMATOMA 5 0.0003
740 CARDIOGENIC SHOCK 5 0.0003
741 IMPAIRED QUALITY OF LIFE 5 0.0003
742 HEAD INJURY 11 0.0003
743 EPISTAXIS 26 0.0003
744 PRODUCT PHYSICAL ISSUE 7 0.0003
745 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
746 MENTAL DISORDER 15 0.0003
747 ORTHOSTATIC HYPOTENSION 6 0.0003
748 LOCAL SWELLING 6 0.0003
749 GASTRITIS 9 0.0003
750 COVID-19 PNEUMONIA 4 0.0003
751 COLON CANCER 5 0.0003
752 ACCIDENT 4 0.0003
753 URINARY TRACT INFECTION 57 0.0003
754 HYPOAESTHESIA ORAL 5 0.0003
755 LIMB INJURY 9 0.0003
756 MENTAL IMPAIRMENT 8 0.0003
757 ECONOMIC PROBLEM 5 0.0003
758 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
759 LOSS OF CONSCIOUSNESS 42 0.0003
760 INSURANCE ISSUE 5 0.0003
761 MYALGIA 55 0.0003
762 NASAL CONGESTION 19 0.0003
763 TENDONITIS 5 0.0003
764 HAEMOPTYSIS 9 0.0003
765 EYE SWELLING 12 0.0003
766 PHARYNGITIS 4 0.0003
767 LUNG INFECTION 5 0.0003
768 OXYGEN SATURATION DECREASED 18 0.0003
769 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
770 BRAIN FOG 5 0.0003
771 RED BLOOD CELL COUNT DECREASED 9 0.0003
772 CONVULSION 18 0.0003
773 HEPATOTOXICITY 7 0.0003
774 CHOLESTASIS 6 0.0003
775 SENSORY DISTURBANCE 5 0.0003
776 HYPOGLYCAEMIA 15 0.0003
777 HAEMATOCHEZIA 17 0.0003
778 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
779 DEHYDRATION 41 0.0003
780 DEAFNESS 8 0.0003
781 VISION BLURRED 42 0.0003
782 MYELOSUPPRESSION 11 0.0003
783 ACUTE MYOCARDIAL INFARCTION 9 0.0003
784 PULMONARY CONGESTION 4 0.0003
785 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
786 HYPERGLYCAEMIA 11 0.0003
787 PANIC ATTACK 11 0.0003
788 DIABETES MELLITUS 23 0.0003
789 EYE PAIN 17 0.0003
790 COGNITIVE DISORDER 14 0.0003
791 BURNING SENSATION 21 0.0003
792 ATRIAL FIBRILLATION 29 0.0003
793 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
794 INTENTIONAL PRODUCT MISUSE 26 0.0003
795 SINUS CONGESTION 4 0.0003
796 FEEDING DISORDER 6 0.0003
797 THROAT TIGHTNESS 8 0.0003
798 OCULAR HYPERAEMIA 14 0.0003
799 DYSPHAGIA 28 0.0003
800 CIRCULATORY COLLAPSE 5 0.0003
801 PERIPHERAL COLDNESS 4 0.0003
802 UNEVALUABLE EVENT 22 0.0003
803 ANAPHYLACTIC REACTION 16 0.0003
804 PULMONARY HYPERTENSION 6 0.0003
805 DEVICE OCCLUSION 4 0.0003
806 RENAL FAILURE ACUTE 12 0.0003
807 CYSTITIS 9 0.0003
808 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
809 EATING DISORDER 6 0.0003
810 EMOTIONAL DISTRESS 34 0.0003
811 IMPAIRED WORK ABILITY 6 0.0003
812 GOUT 5 0.0003
813 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 50 0.0003
814 PARAESTHESIA ORAL 4 0.0003
815 GASTROENTERITIS VIRAL 5 0.0003
816 CHOLELITHIASIS 9 0.0003
817 END STAGE RENAL DISEASE 5 0.0003
818 ACCIDENTAL OVERDOSE 10 0.0003
819 PALPITATIONS 32 0.0003
820 MELAENA 6 0.0003
821 CARDIOMYOPATHY 4 0.0003
822 VIRAL INFECTION 9 0.0003
823 LIP SWELLING 9 0.0003
824 HYPONATRAEMIA 15 0.0003
825 BLOOD POTASSIUM DECREASED 8 0.0003
826 CORONARY ARTERY DISEASE 8 0.0003
827 FOOT FRACTURE 5 0.0003
828 ACUTE KIDNEY INJURY 40 0.0003
829 TINNITUS 12 0.0003
830 NEOPLASM PROGRESSION 9 0.0003
831 RASH MACULAR 9 0.0003
832 EJECTION FRACTION DECREASED 4 0.0003
833 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
834 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
835 BACK PAIN 58 0.0002
836 MOVEMENT DISORDER 8 0.0002
837 SKIN EXFOLIATION 21 0.0002
838 CHILLS 29 0.0002
839 MUSCLE TIGHTNESS 4 0.0002
840 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
841 DISEASE PROGRESSION 29 0.0002
842 METASTASES TO BONE 4 0.0002
843 CONSTIPATION 53 0.0002
844 HYPOTENSION 48 0.0002
845 ABDOMINAL PAIN LOWER 6 0.0002
846 CHRONIC KIDNEY DISEASE 18 0.0002
847 HEMIPARESIS 4 0.0002
848 MUSCULOSKELETAL DISCOMFORT 4 0.0002
849 POOR QUALITY SLEEP 5 0.0002
850 NO ADVERSE EVENT 42 0.0002
851 LACRIMATION INCREASED 7 0.0002
852 NERVOUSNESS 12 0.0002
853 MUCOSAL INFLAMMATION 6 0.0002
854 COLD SWEAT 4 0.0002
855 HEART RATE INCREASED 22 0.0002
856 DRY EYE 11 0.0002
857 BALANCE DISORDER 19 0.0002
858 MOOD SWINGS 7 0.0002
859 PRODUCT AVAILABILITY ISSUE 5 0.0002
860 RESTLESSNESS 8 0.0002
861 RHINORRHOEA 14 0.0002
862 HEPATIC STEATOSIS 4 0.0002
863 MIDDLE INSOMNIA 4 0.0002
864 NEUTROPENIA 29 0.0002
865 EYE DISORDER 7 0.0002
866 BLOOD SODIUM DECREASED 4 0.0002
867 FRACTURE 4 0.0002
868 MUSCULOSKELETAL DISORDER 4 0.0002
869 URINARY RETENTION 7 0.0002
870 PRODUCTIVE COUGH 10 0.0002
871 DERMATITIS ATOPIC 11 0.0002
872 LETHARGY 12 0.0002
873 BLOOD PRESSURE FLUCTUATION 5 0.0002
874 DIABETIC KETOACIDOSIS 5 0.0002
875 DEPRESSED MOOD 11 0.0002
876 BRADYCARDIA 11 0.0002
877 INFLUENZA 23 0.0002
878 PRESYNCOPE 5 0.0002
879 NEURALGIA 5 0.0002
880 DYSPHONIA 12 0.0002
881 BONE PAIN 12 0.0002
882 KIDNEY INFECTION 4 0.0002
883 CATARACT 12 0.0002
884 PULMONARY OEDEMA 9 0.0002
885 UPPER LIMB FRACTURE 4 0.0002
886 SYNCOPE 20 0.0002
887 CYTOKINE RELEASE SYNDROME 4 0.0002
888 SEIZURE 23 0.0002
889 DEVICE BREAKAGE 8 0.0002
890 CARDIOVASCULAR DISORDER 5 0.0002
891 BLINDNESS 8 0.0002
892 BLOOD PRESSURE INCREASED 30 0.0002
893 NEPHROLITHIASIS 9 0.0002
894 RIB FRACTURE 4 0.0002
895 LIMB DISCOMFORT 6 0.0002
896 NERVOUS SYSTEM DISORDER 6 0.0002
897 CARDIO-RESPIRATORY ARREST 8 0.0002
898 PRODUCT DOSE OMISSION ISSUE 56 0.0002
899 ANHEDONIA 5 0.0002
900 DYSURIA 7 0.0002
901 DRUG INTERACTION 30 0.0002
902 DEATH 162 0.0002
903 CARDIAC FAILURE CONGESTIVE 15 0.0002
904 DRUG EFFECT DECREASED 10 0.0002
905 PRURITUS GENERALISED 4 0.0002
906 ILLNESS 19 0.0002
907 MOOD ALTERED 5 0.0002
908 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
909 SUICIDE ATTEMPT 11 0.0002
910 ABNORMAL DREAMS 5 0.0002
911 ANGIOEDEMA 8 0.0002
912 TOOTH DISORDER 4 0.0002
913 ABNORMAL BEHAVIOUR 7 0.0002
914 DISORIENTATION 7 0.0002
915 APPLICATION SITE PRURITUS 4 0.0002
916 INTENTIONAL DOSE OMISSION 5 0.0002
917 ANGINA PECTORIS 5 0.0002
918 HYPERSOMNIA 5 0.0002
919 DEVICE MALFUNCTION 12 0.0002
920 LUNG NEOPLASM MALIGNANT 7 0.0002
921 URINARY INCONTINENCE 5 0.0002
922 DISEASE RECURRENCE 8 0.0002
923 IRRITABILITY 10 0.0002
924 LOCALISED INFECTION 4 0.0002
925 COVID-19 29 0.0002
926 DRUG EFFECT INCOMPLETE 6 0.0002
927 DRUG ADMINISTRATION ERROR 5 0.0002
928 FEMUR FRACTURE 5 0.0002
929 COUGH 45 0.0002
930 SOMNOLENCE 32 0.0002
931 FLATULENCE 9 0.0002
932 CARDIAC ARREST 13 0.0002
933 FLUSHING 16 0.0002
934 EYE IRRITATION 9 0.0002
935 COMPLETED SUICIDE 13 0.0002
936 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
937 HYPERHIDROSIS 20 0.0002
938 HAEMATOMA 4 0.0002
939 HAEMORRHAGE 16 0.0002
940 APPLICATION SITE ERYTHEMA 4 0.0002
941 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
942 VISUAL ACUITY REDUCED 5 0.0002
943 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
944 PALLOR 4 0.0001
945 CHEST DISCOMFORT 15 0.0001
946 RESPIRATORY ARREST 4 0.0001
947 FEELING COLD 4 0.0001
948 CEREBRAL HAEMORRHAGE 5 0.0001
949 SURGERY 8 0.0001
950 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
951 APHASIA 4 0.0001
952 INJECTION SITE RASH 4 0.0001
953 CARDIAC DISORDER 12 0.0001
954 ARRHYTHMIA 6 0.0001
955 LACTIC ACIDOSIS 4 0.0001
956 DYSKINESIA 5 0.0001
957 TREMOR 20 0.0001
958 EYE PRURITUS 4 0.0001
959 HEART RATE DECREASED 4 0.0001
960 THERAPY INTERRUPTED 8 0.0001
961 AGITATION 8 0.0001
962 DYSARTHRIA 4 0.0001
963 COMA 5 0.0001
964 MULTIPLE SCLEROSIS 5 0.0001
965 POLLAKIURIA 4 0.0001
966 TOXICITY TO VARIOUS AGENTS 16 0.0001
967 CEREBROVASCULAR ACCIDENT 16 0.0001
968 HOT FLUSH 7 0.0001
969 DISTURBANCE IN ATTENTION 5 0.0001
970 INJECTION SITE BRUISING 7 0.0001
971 SKIN IRRITATION 4 0.0001
972 PRODUCT SUBSTITUTION ISSUE 5 0.0001
973 BLOOD GLUCOSE DECREASED 4 0.0001
974 HALLUCINATION 6 0.0001
975 INJECTION SITE SWELLING 6 0.0001
976 DEVICE ISSUE 6 0.0001
977 INJECTION SITE PAIN 20 0.0001
978 BLOOD GLUCOSE INCREASED 12 0.0001
979 INTENTIONAL OVERDOSE 4 0.0001
980 DRUG ABUSE 5 0.0001
981 PRODUCT STORAGE ERROR 5 0.0001
982 DRUG WITHDRAWAL SYNDROME 5 0.0001
983 SKIN BURNING SENSATION 4 0.0001
984 BREAST CANCER 5 0.0001
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
987 INJECTION SITE ERYTHEMA 6 0.0000
988 INCORRECT DOSE ADMINISTERED 9 0.0000
989 DRUG DEPENDENCE 6 0.0000
990 DRUG DOSE OMISSION 5 0.0000